- Trials with a EudraCT protocol (357)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (0)
357 result(s) found for: Outpatient care.
Displaying page 1 of 18.
EudraCT Number: 2020-000233-41 | Sponsor Protocol Number: OPTION | Start Date*: 2020-08-25 |
Sponsor Name:Sahlgrenska University Hospital | ||
Full Title: Labour induction in an outpatient setting - a multicenter randomized controlled trial. OPTION - OutPatienT InductiON | ||
Medical condition: Induction of labour | ||
Disease: | ||
Population Age: In utero, Under 18, Adults | Gender: Male, Female | |
Trial protocol: SE (Trial now transitioned) | ||
Trial results: (No results available) |
EudraCT Number: 2008-002106-19 | Sponsor Protocol Number: | Start Date*: 2008-07-10 |
Sponsor Name:Chelsea & Westminster NHS Foundation Trust | ||
Full Title: Remifentanil sedation for outpatient endoscopic procedures | ||
Medical condition: We are investigating the use of remifentanil for sedation in outpatient endoscopic procedures. It will be compared to 'current practice' sedation with midazolam and fentanyl. Patient who are due to... | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: GB (Prematurely Ended) | ||
Trial results: View results |
EudraCT Number: 2021-006504-32 | Sponsor Protocol Number: ACTIV-2d/A5407 | Start Date*: 2022-12-15 | |||||||||||
Sponsor Name:Shionogi B.V. | |||||||||||||
Full Title: A Phase 3, multicenter, randomized, double-blind, 24-week study of the clinical and antiviral effect of S-217622 compared with placebo in non-hospitalized participants with COVID-19 | |||||||||||||
Medical condition: SARS-CoV-2 infection | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: PL (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2020-001752-17 | Sponsor Protocol Number: PI20208430039 | Start Date*: 2020-05-13 |
Sponsor Name:CHU Amiens Picardie | ||
Full Title: Proactive Management of Outpatient Covid-19 Patients : a randomised controlled trial | ||
Medical condition: Infection SARS-CoV-2 | ||
Disease: | ||
Population Age: | Gender: | |
Trial protocol: FR (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2019-003522-25 | Sponsor Protocol Number: APHP180672 | Start Date*: 2020-02-28 |
Sponsor Name:AP-HP | ||
Full Title: | ||
Medical condition: acute osteomyelitis of the child | ||
Disease: | ||
Population Age: Children, Under 18 | Gender: Male, Female | |
Trial protocol: FR (Trial now transitioned) | ||
Trial results: (No results available) |
EudraCT Number: 2019-004890-21 | Sponsor Protocol Number: NL72427.068.19 | Start Date*: 2021-01-18 |
Sponsor Name:Academic Hospital Maastricht (azM) | ||
Full Title: Effectiveness of Periocular drug Injection in CATaract surgery | ||
Medical condition: cystoid macular edema (CME) | ||
Disease: | ||
Population Age: Elderly | Gender: Male, Female | |
Trial protocol: NL (Prematurely Ended) DE (Prematurely Ended) AT (Prematurely Ended) PT (Prematurely Ended) | ||
Trial results: View results |
EudraCT Number: 2016-001528-69 | Sponsor Protocol Number: EmergencyMedicineTrial001 | Start Date*: 2016-10-07 |
Sponsor Name:Royal College of Surgeons in Ireland | ||
Full Title: PENICILLIN FOR THE EMERGENCY DEPARTMENT-DIRECTED OUTPATIENT TREATMENT OF CELLULITIS (PEDOCELL) STUDY: A NON-INFERIORITY ADAPTIVE RANDOMISED CONTROLLED TRIAL. | ||
Medical condition: Skin Infection | ||
Disease: | ||
Population Age: Adolescents, Under 18, Adults, Elderly | Gender: Male, Female | |
Trial protocol: IE (Prematurely Ended) | ||
Trial results: View results |
EudraCT Number: 2021-003703-18 | Sponsor Protocol Number: 2021/04 | Start Date*: 2021-09-14 | ||||||||||||||||||||||||||
Sponsor Name:CMC Ambroise Paré | ||||||||||||||||||||||||||||
Full Title: Opioid free anesthesia in total hip arthroplasty. A randomized, controlled and triple-blind clinical trial. | ||||||||||||||||||||||||||||
Medical condition: Total hip arthroplasty | ||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||||||||||||
Trial protocol: FR (Completed) | ||||||||||||||||||||||||||||
Trial results: View results |
EudraCT Number: 2020-001622-64 | Sponsor Protocol Number: TAC-COVID19 | Start Date*: 2020-04-19 |
Sponsor Name:Dra Ana Pueyo Bastida | ||
Full Title: OUTPATIENT TREATMENT OF COVID-19 WITH EARLY PULMONARY CORTICOSTEROIDS AS AN OPPORTUNITY TO MODIFY THE COURSE OF THE DISEASE | ||
Medical condition: COVID-19 | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: ES (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2015-005274-38 | Sponsor Protocol Number: BRONSE | Start Date*: 2016-03-10 |
Sponsor Name:Region Östergötland | ||
Full Title: Patient-controlled sedation with propofol versus combined sedation during bronchoscopy – a randomized controlled trial | ||
Medical condition: Diagnostic bronchoscopy for referred outpatients | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: SE (Completed) | ||
Trial results: View results |
EudraCT Number: 2019-002779-32 | Sponsor Protocol Number: PREEMTIVE | Start Date*: 2019-12-26 |
Sponsor Name:BERTA CASTELLANO PAULIS | ||
Full Title: “Pre-emptive analgesia with Ibuprofen in outpatient laparoscopic cholecystectomy. Recovery Quality ” | ||
Medical condition: AMBULATORY LAPAROSCOPIC COLECISTECTOMY | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: ES (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2007-003769-41 | Sponsor Protocol Number: ALB1 | Start Date*: 2008-01-31 | |||||||||||
Sponsor Name:Medical University Graz | |||||||||||||
Full Title: Albumin in acute-on-chronic liver failure: More than just volume? A randomized, controlled study | |||||||||||||
Medical condition: Spntaneous bacterial peritonitis | |||||||||||||
|
|||||||||||||
Population Age: | Gender: Male, Female | ||||||||||||
Trial protocol: AT (Completed) | |||||||||||||
Trial results: Removed from public view |
EudraCT Number: 2020-003510-12 | Sponsor Protocol Number: GS-US-540-9012 | Start Date*: 2020-10-02 | |||||||||||
Sponsor Name:Gilead Sciences, Inc | |||||||||||||
Full Title: A Phase 3 Randomized, Double-Blind Placebo-Controlled Trial to Evaluate the Efficacy and Safety of Remdesivir (GS-5734™) Treatment of COVID-19 in an Outpatient Setting | |||||||||||||
Medical condition: COVID-19 | |||||||||||||
|
|||||||||||||
Population Age: Adolescents, Under 18, Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DK (Completed) GB (GB - no longer in EU/EEA) PT (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2015-002769-44 | Sponsor Protocol Number: ESAP | Start Date*: 2015-09-28 | |||||||||||
Sponsor Name:Medical University of Graz | |||||||||||||
Full Title: Efficacy and safety of an accelerated outpatient protocol for hymenoptera venom immunotherapy | |||||||||||||
Medical condition: Immunotherapy against systemic anaphylactic sting reactions | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: AT (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2015-001714-96 | Sponsor Protocol Number: R2222-RSV-1332 | Start Date*: 2015-11-03 | |||||||||||
Sponsor Name:Regeneron Pharmaceuticals, Inc. | |||||||||||||
Full Title: A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study Evaluating the Efficacy and Safety of a Human Monoclonal Antibody, REGN2222, for the Prevention of Medically Attended RSV Infection in ... | |||||||||||||
Medical condition: Medically attended respiratory syncytial virus infection | |||||||||||||
|
|||||||||||||
Population Age: Preterm newborn infants, Infants and toddlers, Under 18 | Gender: Male, Female | ||||||||||||
Trial protocol: DK (Completed) GB (Completed) HU (Completed) FI (Completed) BG (Completed) ES (Completed) CZ (Completed) NL (Completed) DE (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2014-002425-35 | Sponsor Protocol Number: NL2014-002425-35/SpartacusBrindisi | Start Date*: 2015-07-20 |
Sponsor Name:National Poisons Information Center, University Medical Center Utrecht | ||
Full Title: A Single Centered, Prospective, Open-labeled, Pharmacokinetic Pilot Study of Tacrolimus Administration via Rectiole | ||
Medical condition: Heart and lung transplantation patients | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: NL (Prematurely Ended) | ||
Trial results: View results |
EudraCT Number: 2014-002514-23 | Sponsor Protocol Number: Car20130917 | Start Date*: 2015-01-07 |
Sponsor Name:VU Medical Center | ||
Full Title: Reduction Of Microvascular Injury Utilizing Sonolysis | ||
Medical condition: Myocardial infarction | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: NL (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2015-004887-13 | Sponsor Protocol Number: ADA113872 | Start Date*: 2016-12-21 |
Sponsor Name:GlaxoSmithKline Research & Development Ltd | ||
Full Title: A Randomized, Double-Blind, Parallel Group study of ADVAIR™ DISKUS™ 100/50 and FLOVENT™DISKUS™ 100, both twice daily, in a Pediatric Population during the Fall Viral Season. | ||
Medical condition: Asthma | ||
Disease: | ||
Population Age: Children, Under 18 | Gender: Male, Female | |
Trial protocol: Outside EU/EEA | ||
Trial results: View results |
EudraCT Number: 2017-004588-11 | Sponsor Protocol Number: ABR64005 | Start Date*: 2019-09-10 |
Sponsor Name:University Maastricht | ||
Full Title: Control Crohn Safe Trial: Long term efficacy and safety of periodic treatment with adalimumab versus standard step-care for newly diagnosed Crohn's disease. | ||
Medical condition: The chronic inflammatory bowel disease Crohn's disease | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: NL (Trial now transitioned) | ||
Trial results: (No results available) |
EudraCT Number: 2013-000290-73 | Sponsor Protocol Number: FCVHPC-2013-01 | Start Date*: 2013-06-21 | |||||||||||
Sponsor Name:FUNDACION C.V. HOSPITAL PROVINCIAL DE CASTELLON | |||||||||||||
Full Title: Randomized, double-blind, phase IV trial comparing the efficacy of two methods of sedation in patients scheduled for outpatient diagnostic-therapeutic colonoscopy. | |||||||||||||
Medical condition: Sedation in patients (whose colonoscopy has been scheduled) with inhalatory sevorane versus standard intravenous sedation. | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: ES (Completed) | |||||||||||||
Trial results: View results |
Subscribe to this Search
To subscribe to the RSS feed for this search click here
.
This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here

Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
